GC Biopharma seeks approval for COVID-19 mRNA vaccine trial in Korea
PositiveFinancial Markets

GC Biopharma is making strides in the fight against COVID-19 by seeking approval for a new mRNA vaccine trial in Korea. This initiative is significant as it could enhance the country's vaccine arsenal and contribute to global efforts in combating the pandemic. With mRNA technology proving effective in previous vaccines, this trial could pave the way for more innovative solutions to protect public health.
— Curated by the World Pulse Now AI Editorial System